Mill Creek Capital Advisors LLC trimmed its position in CVS Health Co. (NYSE:CVS – Free Report) by 2.2% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 12,249 shares of the pharmacy operator’s stock after selling 275 shares during the period. Mill Creek Capital Advisors LLC’s holdings in CVS Health were worth $770,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Livelsberger Financial Advisory acquired a new stake in CVS Health in the 3rd quarter valued at about $31,000. Reston Wealth Management LLC purchased a new stake in CVS Health during the third quarter valued at about $32,000. First Community Trust NA increased its position in shares of CVS Health by 116.2% in the second quarter. First Community Trust NA now owns 562 shares of the pharmacy operator’s stock worth $33,000 after acquiring an additional 302 shares in the last quarter. Kathleen S. Wright Associates Inc. acquired a new stake in shares of CVS Health during the third quarter valued at approximately $33,000. Finally, ORG Partners LLC boosted its stake in CVS Health by 11,840.0% in the 2nd quarter. ORG Partners LLC now owns 597 shares of the pharmacy operator’s stock worth $35,000 after purchasing an additional 592 shares during the period. 80.66% of the stock is owned by institutional investors.
Analyst Ratings Changes
Several research analysts recently weighed in on the company. Deutsche Bank Aktiengesellschaft dropped their price target on CVS Health from $64.00 to $63.00 and set a “hold” rating on the stock in a research report on Friday, August 9th. UBS Group raised their price target on CVS Health from $60.00 to $62.00 and gave the stock a “neutral” rating in a research note on Thursday, November 7th. Truist Financial boosted their price target on CVS Health from $66.00 to $76.00 and gave the company a “buy” rating in a research note on Friday, October 11th. Royal Bank of Canada cut their price objective on shares of CVS Health from $68.00 to $58.00 and set an “outperform” rating on the stock in a research report on Friday. Finally, Barclays decreased their target price on shares of CVS Health from $75.00 to $71.00 and set an “overweight” rating for the company in a research report on Thursday, November 7th. One equities research analyst has rated the stock with a sell rating, eight have assigned a hold rating and twelve have given a buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $72.44.
CVS Health Trading Down 3.4 %
Shares of CVS stock opened at $53.19 on Friday. The firm has a market capitalization of $66.93 billion, a P/E ratio of 13.50, a price-to-earnings-growth ratio of 0.92 and a beta of 0.55. CVS Health Co. has a 1 year low of $52.71 and a 1 year high of $83.25. The firm’s fifty day simple moving average is $59.23 and its 200 day simple moving average is $58.66. The company has a current ratio of 0.80, a quick ratio of 0.59 and a debt-to-equity ratio of 0.80.
CVS Health (NYSE:CVS – Get Free Report) last posted its quarterly earnings data on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.08 by $0.01. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. The company had revenue of $95.43 billion for the quarter, compared to the consensus estimate of $92.72 billion. During the same quarter in the previous year, the firm posted $2.21 EPS. The business’s revenue was up 6.3% compared to the same quarter last year. As a group, sell-side analysts predict that CVS Health Co. will post 5.48 EPS for the current year.
CVS Health Announces Dividend
The company also recently announced a quarterly dividend, which was paid on Friday, November 1st. Investors of record on Monday, October 21st were paid a $0.665 dividend. The ex-dividend date of this dividend was Monday, October 21st. This represents a $2.66 dividend on an annualized basis and a dividend yield of 5.00%. CVS Health’s payout ratio is 67.51%.
CVS Health Company Profile
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.
Read More
- Five stocks we like better than CVS Health
- How to Most Effectively Use the MarketBeat Earnings Screener
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
- 2 Rising CRM Platform Stocks That Can Surge Higher in 2025
- Freeport-McMoRan, Copper Demand Short-Term Pain, Long-Term Gain
- Why Invest in High-Yield Dividend Stocks?
- Time to Load Up on Home Builders?
Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Co. (NYSE:CVS – Free Report).
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.